| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.051 | 0.06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |